Clinical and biological evaluation in the management of patients with rheumatoid arthritis: Recommendations for clinical practice based on published data and expert opinions (Discussions among rheumatology experts);L'évaluation clinique et biologique dans la prise en charge de personnes souffrant de polyarthrite rhumatoïde établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (Rencontres d'experts en rhumatologie)

Revue du Rhumatisme (Edition Francaise)

Volumn 71, Issue SUPPL. 5, 2004, Pages

  Pham, Thao ^a   Gossec, Laure ^b   Fautrel, Bruno ^c   Combe, Bernard ^d   Flipo, René Marc ^e   Goupille, Philippe ^f   Le Loët, Xavier ^g   Mariette, Xavier ^h   Puéchal, Xavier ⁱ   Wendlin, Daniel ^j   Schaeverbeke, Thierry ^k   Sibilia, Jean ^l   Sany, Jacques ^d   Dougadose, Maxime ^c  

^a HÔPITAL DE LA CONCEPTION   (France)

^b Hôpital Cochin ^*  (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d LAPEYRONIE HOSPITAL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF TOURS   (France)

^g Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^h BICÊTRE HOSPITAL   (France)

ⁱ CENTRE HOSPITALIER   (France)

^j UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^k HÔPITAL PELLEGRIN   (France)

^l HÔPITAL DE HAUTEPIERRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT;

ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DISEASE SEVERITY; HUMAN; MEDICAL LITERATURE; MEDICAL PROFESSION; PATIENT SELECTION; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; PUBLICATION; RHEUMATOID ARTHRITIS; TREATMENT PLANNING;

EID: 19944427244     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(04)80002-4     Document Type: Article

References (52)

1. Davis R.M. Wagner E.G. Groves T. Advances in managing chronic disease. Research, performance measurement, and quality improvement are key BMJ 320 2000 525-526
2. Boers M. Tugwell P. Felson D.T. van Riel P.L. Kirwan J.R. Edmonds J.P. et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs inrheumatoid arthritis clinical trials J Rheumatol Suppl 41 1994 86-89
3. Boers M. Felson D.T. Clinical measures in rheumatoid arthritis which are most useful in assessing patients ? J Rheumatol 21 1994 1773-1774
4. Tugwell P. Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee J Rheumatol 20 1993 555-556
5. Tugwell P. Boers M. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials : Introduction J Rheumatol 20 1993 528-530
6. Felson D.T. Anderson J.J. Boers M. Bombardier C. Chernoff M. Fried B. et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee onOutcome Measures in Rheumatoid Arthritis Clinical Trials Arthritis Rheum 36 1993 729-740
7. Pincus T. Sokka T. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care Best Pract Res Clin Rheumatol 17 2003 753-781
8. van Riel P.L. van Gestel A.M. van de Putte L.B. Development and validation of response criteria in rheumatoid arthritis : Steps towards an international consensus on prognostic markers Br J Rheumatol 35 Suppl 2 1996 4-7
9. van der Heijde D.M. van't Hof M. van Riel P.L. van de Putte L.B. Development of a disease activity score based on judgment in clinical practice by rheumatologists J Rheumatol 20 1993 579-581
10. (in press) Gossec L. Fautrel B. Pham T. Combe B. Flipo R. Goupille P. et al. L'évaluation structurale dans la prise en charge de personnes souffrant de polyarthrite rhumatoïde : Établissement de recommandations pour lapratique clinique à partir de données de la littérature et d'opinions d'experts (Rencontres d'Experts en Rhumatologie) Joint Bone Spine 2004
11. (in press) Fautrel B. Pham T. Gossec L. Combe B. Flipo R. Goupille P. et al. Place et forme de l'information et de l'éducation dans la prise en charge de personnes souffrant de polyarthrite rhumatoïde : Établisse ment de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (Rencontres d'Experts en Rhumatologie) Joint Bone Spine 2004
12. Shekelle P.G. Woolf S.H. Eccles M. Grimshaw J. Clinical guidelines developing guidelines BMJ 318 1999 593-596
13. Prevoo M.L. van't Hof M.A. Kuper H.H. van Leeuwen M.A. van de Putte L.B. van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospec tive longitudinal study ofpatients with rheumatoid arthritis Arthritis Rheum 38 1995 44-48
14. Porter R.D. Grigor C. Stirling A. Capel H.A. A randomized controlled trial of strategy of tight control of disease activity in rheumatoid arthritis-outcome over 18 months Arthritis Rheum 48 2003 S232-s2
15. Fransen J. Speyer I. Moens H. van Riel P. The effectiveness of systematic monitoring of RA disease activity in dialy practice (TRAC) a multicentre cluster-RCT Ann Rheum Dis 63 2004 84
16. Smolen I.S. Breedveld F.C. Schiff M.H. Kalden J.R. Emery P. Eberl G. et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice Rheumatology (Oxford) 42 2003 244-257
17. van Riel P.L. van de Putte L.B. Clinical assessment and clinical trials in rheumatoid arthritis Curr Opin Rheumatol 6 1994 132-139
18. van der Heijde D.M. van't Hof M.A. van Riel P.L. Theunisse L.A. Lubberts E.W. van Leeuwen M.A. et al. Judging disease activity in clinical practice in rheumatoid arthritis : First step in the development of a disease activity score Ann Rheum Dis 49 1990 916-920
19. Boers M. van Riel P.L. Felson D.T. Tugwell P. Assessing the activity of rheumatoid arthritis Baillieres Clin Rheumatol 9 1995 305-317
20. van Gestel A.M. Anderson J.J. van Riel P.L. Boers M. Haagsma C.J. Rich B. et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League ofAssociations for Rheumatology J Rheumatol 26 1999 705-711
21. Mason J.H. Meenan R.F. Anderson J.J. Do self-reported arthritis symptom (RADAR) and health status (AIMS2) data provide duplicative or complementary information ? Arthritis Care Res 5 1992 163-172
22. Fransen J. Langenegger T. Michel B.A. Stucki G. Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index Rheumatology (Oxford) 39 2000 321-327
23. Fuchs H.A. Brooks R.H. Callahan L.F. Pincus T. A simplified twentyeight-joint quantitative articular index in rheumatoid arthritis Arthritis Rheum 32 1989 531-537
24. Ritchie D.A. Boyle J.A. McInnes J.M. Jasani M.K. Dalakos T.G. Grieveson P. et al. Evaluation of a simple articular index for joint tenderness in rheumatoid arthritis. Clinical studies with an articular index for the assessment ofjoint tenderness in patients with rheumatoid arthritis Ann Rheum Dis 28 1969 196
25. Ritchie D.M. Boyle J.A. McInnes J.M. Jasani M.K. Dalakos T.G. Grieveson P. et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis Q J Med 37 1968 393-406
26. Egger M.J. Huth D.A. Ward J.R. Reading J.C. Williams H.J. Reduced joint count indices in the evaluation of rheumatoid arthritis Arthritis Rheum 28 1985 613-619
27. Pincus T. Brooks R.H. Callahan L.F. A proposed 30-45 minute 4 page standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes J Rheumatol 26 1999 473-480
28. Fuchs H.A. Callahan L.F. Kaye J.J. Brooks R.H. Nance E.P. Pincus T. Radiographic and joint count findings of the hand in rheumatoid arthritis. Related and unrelated findings Arthritis Rheum 31 1988 44-51
29. Birrell F.N. Hassell A.B. Jones P.W. Dawes P.T. Why not use OSRA ? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RA J Rheumatol 25 1998 1709-1715
30. Fries J.F. Spitz P. Kraines R.G. Holman H.R. Measurement of patient outcome in arthritis Arthritis Rheum 23 1980 137-145
31. Guillemin F. Braincon S. Pourel J. Measurement of the functional capacity in rheumatoid polyarthritis : A French adaptation of the Health Assessment Questionnaire (HAQ) Rev Rhum Mal Ostecartic 58 1991 459-465
32. Greenwood M.C. Doyle D.V. Ensor M. Does the Stanford Health Assessment Questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis ? Ann Rheum Dis 60 2001 344-348
33. Felson D.T. Anderson J.J. Boers M. Bombardier C. Furst D. Goldsmith C. et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 1995 727-735
34. Kirwan J. Hewlett S. Mitchell K. Hehir M. Pollock J. Blair P. et al. RCT of patient-initiated review versus regular physician-initiated follow-up in rheumatoid arthritis, extended to 6 years Ann Rheum Dis 63 2004 75
35. Kirwan J.R. Mitchell K. Hewlett S. Hehir M. Pollock J. Memel D. et al. Clinical and psychological outcome from a randomized controlled trial of patient-initiated direct-access hospital follow-up for rheuma toidarthritis extended to 4 years Rheumatology (Oxford) 42 2003 422-426
36. Combe B. Cantagrel A. Goupille P. Bozonnat M.C. Sibilia J. Eliaou J.F. et al. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis J Rheumatol 30 2003 2344-2349
37. Bukhari M. Lunt M. Harrison B.J. Scott D.G. Symmons D.P. Silman A.J. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis : Results from the NorfolkArthritis Register Study, a large inception cohort Arthritis Rheum 46 2002 906-912
38. Goronzy J.J. Matteson E.L. Fulbright J.W. Warrington K.J. ChangMiller A. Hunder G.G. et al. Prognostic markers of radiographic progression in early rheumatoid arthritis Arthritis Rheum 50 2004 43-54
39. Meyer O. Labarre C. Dougados M. Goupille P. Cantagrel A. Dubois A. et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Ann Rheum Dis 62 2003 120-126
40. Vencovsky J. Machacek S. Sedova L. Kafkova J. Gatterova J. Pesakova V. et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis Ann Rheum Dis 62 2003 427-430
41. Van Gaalen F.A. Van Aken J. Huizinga T.W. Schreuder G.M. Breedveld F.C. Zanelli E. et al. Association between HLA class 11 genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis Arthritis Rheum 50 2004 2113-2121
42. Drossaers-Bakker K.W. Zwinderman A.H. Vlieland T.P. Van Zeben D. Vos K. Breedveld F.C. et al. Long-term outcome in rheumatoid arthritis : A simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year follow-up Arthritis Rheum 47 2002 383-390
43. Wiles N.J. Dunn G. Barrett E.M. Harrison B.J. Silman A.J. Symmons D.P. One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline J Rheumatol 27 2000 2360-2366
44. van Jaarsveid C.H. ter Borg E.J. Jacobs J.W. Schellekens G.A. Gmelig-Meyling F.H. van Booma-Frankfort C. et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis Clin Exp Rheumatol 17 1999 689-697
45. Dixey J. Solymossy C. Young A. Is it possible to predict radiological damage in early rheumatoid arthritis (RA) 7 A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS) J Rheumatol Suppl 69 2004 48-54
46. Valenzuela-Castano A. Garcia-Lopez A. Perez-Vilches D. Rodriguez-Perez R. Gonzalez-Escribano M.F. Nunez-Roldan A. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 yearobservational prospective study J Rheumatol 27 2000 571-574
47. Moreno I. Valenzuela A. Garcia A. Yelamos J. Sanchez B. Hemanz W. Association of the shared epitope with radiological severity of rheumatoid arthritis J Rheumatol 23 1996 6-9
48. Mattey D.L. Hassell A.B. Dawes P.T. Cheung N.T. Poulton K.V. Thomson W. et al. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis Arthritis Rheum 44 2001 1529-1533
49. Kaltenhauser S. Wagner U. Schuster E. Wassmuth R. Arnold S. Seidel W. et al. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity J Rheumatol 28 2001 735-744
50. Wolfe F. Michaud K. Gefeller O. Choi H.K. Predicting mortality in patients with rheumatoid arthritis Arthritis Rheum 48 2003 1530-1542
51. Safety update TNFα blocking agents
52. Dougados M. Betteridge N. Burmester G. Eulier-Ziegler L. Guillemin F. Hirvonen J. et al. EULAR Standardized Operating Procedures for the Elaboration, evaluation, dissemination and implementation of recommendations endorsed by EULAR standing committee Ann Rheum Dis 63 2004 1172-1176